Literature DB >> 22259642

Current methods of visual rehabilitation.

Susanne Trauzettel-Klosinski1.   

Abstract

BACKGROUND: Despite therapeutic progress, many diseases of the eyes and visual pathways still cause persistent visual deficits that make everyday life more difficult in many ways. Rehabilitation aims to compensate for these limitations by optimizing residual vision. The demand for visual rehabilitation will increase markedly in the near future.
METHODS: We summarize the state of the art in visual rehabilitation on the basis of a selective review of the literature, including randomized, controlled trials (RCTs) in the Cochrane and PubMed databases as well as Cochrane reviews. We also pay particular attention to studies illustrating an important principle or a clinically established method.
RESULTS: Central visual field defects impair reading. Persons with an absolute central scotoma can regain reading ability by eccentric fixation and text magnification. Many kinds of magnifying visual aids are available. Specific reading training can further improve reading speed. Peripheral field defects impair orientation. Persons with a concentric field defect can be helped by tactile aids, such as a cane, and with orientation and mobility training. Persons with hemianopia can benefit from compensatory saccadic training.
CONCLUSION: Suitable rehabilitative measures chosen after the thorough diagnostic evaluation of a visual impairment and analysis of its effects can usually restore reading ability, improve orientation, and thereby enhance the patient's independence and quality of life. As the demand for visual rehabilitation is increasing, steps will need to be taken to make it more widely available. Furthermore, as the scientific basis for visual rehabilitation is currently inadequate in some areas, more research in the field will be needed.

Entities:  

Mesh:

Year:  2011        PMID: 22259642      PMCID: PMC3258578          DOI: 10.3238/arztebl.2011.0871

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


  65 in total

1.  Disappointing results from Nova Vision's visual restoration therapy.

Authors:  J C Horton
Journal:  Br J Ophthalmol       Date:  2005-01       Impact factor: 4.638

2.  Improvement of visual search after audiovisual exploration training in hemianopic patients.

Authors:  Ingo Keller; Gudrun Lefin-Rank
Journal:  Neurorehabil Neural Repair       Date:  2010-09       Impact factor: 3.919

3.  Visual exploration training is no better than attention training for treating hemianopia.

Authors:  Alison R Lane; Daniel T Smith; Amanda Ellison; Thomas Schenk
Journal:  Brain       Date:  2010-04-28       Impact factor: 13.501

4.  Computer-based training for the treatment of partial blindness.

Authors:  E Kasten; S Wüst; W Behrens-Baumann; B A Sabel
Journal:  Nat Med       Date:  1998-09       Impact factor: 53.440

5.  The importance of sustained attention for patients with maculopathies.

Authors:  E Altpeter; M Mackeben; S Trauzettel-Klosinski
Journal:  Vision Res       Date:  2000       Impact factor: 1.886

Review 6.  [Blindness in Germany--today and in 2030].

Authors:  C Knauer; N Pfeiffer
Journal:  Ophthalmologe       Date:  2006-09       Impact factor: 1.059

Review 7.  Orientation and mobility training for adults with low vision.

Authors:  Gianni Virgili; Gary Rubin
Journal:  Cochrane Database Syst Rev       Date:  2010-05-12

8.  Restitution of visual function in patients with cerebral blindness.

Authors:  J Zihl; D von Cramon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1979-04       Impact factor: 10.154

9.  Visual field rehabilitation in the cortically blind?

Authors:  R Balliet; K M Blood; P Bach-y-Rita
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-11       Impact factor: 10.154

10.  Optokinetic therapy improves text reading in patients with hemianopic alexia: a controlled trial.

Authors:  G A Spitzyna; R J S Wise; S A McDonald; G T Plant; D Kidd; H Crewes; A P Leff
Journal:  Neurology       Date:  2007-05-29       Impact factor: 9.910

View more
  12 in total

1.  [Visual rehabilitation training for homonymous field defects].

Authors:  S Trauzettel-Klosinski
Journal:  Ophthalmologe       Date:  2012-05       Impact factor: 1.059

2.  Adults should be treated too.

Authors:  Dieter Schmidt
Journal:  Dtsch Arztebl Int       Date:  2012-05-04       Impact factor: 5.594

3.  [Disorders of visual perception].

Authors:  S Schuett; J Zihl
Journal:  Nervenarzt       Date:  2012-08       Impact factor: 1.214

4.  [Current possibilities of visual rehabilitation].

Authors:  S Trauzettel-Klosinski
Journal:  Ophthalmologe       Date:  2018-10       Impact factor: 1.059

5.  Rehabilitation of damage to the visual brain.

Authors:  S Ajina; C Kennard
Journal:  Rev Neurol (Paris)       Date:  2012-09-13       Impact factor: 2.607

Review 6.  Adaptation, perceptual learning, and plasticity of brain functions.

Authors:  Jonathan C Horton; Manfred Fahle; Theo Mulder; Susanne Trauzettel-Klosinski
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-01-14       Impact factor: 3.117

7.  Stroke Survivor and Caregiver Perspectives on Post-Stroke Visual Concerns and Long-Term Consequences.

Authors:  Theresa M Smith; Monique R Pappadis; Shilpa Krishnan; Timothy A Reistetter
Journal:  Behav Neurol       Date:  2018-10-04       Impact factor: 3.342

8.  Diagnosis and rehabilitation of visual field defects in stroke patients: a retrospective audit.

Authors:  K M Sand; L Thomassen; H Næss; E Rødahl; J M Hoff
Journal:  Cerebrovasc Dis Extra       Date:  2012-03-22

Review 9.  Visual rehabilitation: visual scanning, multisensory stimulation and vision restoration trainings.

Authors:  Neil M Dundon; Caterina Bertini; Elisabetta Làdavas; Bernhard A Sabel; Carolin Gall
Journal:  Front Behav Neurosci       Date:  2015-07-27       Impact factor: 3.558

10.  Scotoma Simulation in Healthy Subjects.

Authors:  Sascha Klee; Dietmar Link; Stefan Sinzinger; Jens Haueisen
Journal:  Optom Vis Sci       Date:  2018-12       Impact factor: 1.973

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.